Healthcare
Revenue Exposure
Entire business is healthcare distribution and products; US healthcare environment shifts (value-based payments, shift out of hospitals) affect demand.
Relevance 95·Dependency 90·Confidence 95
Source evidence
“Changes to the U.S. healthcare environment may not be favorable to us.”
CVS Health
Customer Exposure
CVS Health represented 28% of fiscal 2026 revenue and 22% of gross trade receivables, creating significant sales and credit concentration.
Relevance 95·Dependency 90·Confidence 99
Source evidence
“In fiscal 2026, CVS Health was our largest customer. CVS Health accounted for 28 percent of our fiscal 2026 revenue and 22 percent of our gross trade receivable balance at June 30, 2026.”
Hospitals, pharmacies, and other healthcare providers
Revenue Exposure
Revenue is generated from distribution to healthcare provider customers across hospital, pharmacy, lab, and office settings.
Relevance 95·Dependency 90·Confidence 95
Source evidence
“providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices”
National opioid litigation settlements (NOSA)
Legal Exposure
$4.3B accrued at June 30, 2026 with payments through 2038; FY2026 payments $417M and annual NOSA payments ($366M in FY2026, $374M in July 2026) represent a material multi-year cash obligation.
Relevance 92·Dependency 85·Confidence 96
Source evidence
“We have $4.3 billion accrued at June 30, 2026 related to certain national opioid litigation settlements”
Hospitals, healthcare systems, ambulatory surgery centers, clinical labs, physician offices
Customer Exposure
Pharma and GMPD segments distribute products and services to hospitals, healthcare systems, ambulatory surgery centers, clinical laboratories, and physician offices in the US and Canada.
Relevance 90·Dependency 85·Confidence 95
Source evidence
“distributes a broad range of medical, surgical, and laboratory products known as national brand products to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers in the United States and Canada”
Pharmaceutical manufacturers
Supplier Dependency
The Pharma segment distributes products on behalf of pharmaceutical manufacturers and provides services to them, making manufacturers key supply partners for distribution revenue.
Relevance 88·Dependency 82·Confidence 90
Source evidence
“This segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products”
Retail pharmacies (chain and independent drug stores, supermarket/mass merchandiser pharmacy departments)
Customer Exposure
Pharmaceutical Distribution delivers branded, generic, and OTC products to retail pharmacy customers under prime vendor relationships.
Relevance 85·Dependency 80·Confidence 95
Source evidence
“distributes branded and generic pharmaceutical and over-the-counter healthcare and consumer products to retailers (including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers), hospitals, and other healthcare providers”
Specialty pharmaceutical products
Revenue Exposure
Specialty businesses distribute specialty pharmaceuticals (oncology, rheumatology, etc.) and human-derived plasma products and support physician practices via MSO platforms, a key growth business within the Pharma segment.
Relevance 85·Dependency 80·Confidence 90
Source evidence
“distributes specialty pharmaceutical products to hospitals, specialty pharmacies, and other healthcare providers and provides consulting, patient support, and other services for specialty pharmaceutical products to pharmaceutical manufacturers and healthcare providers”
Cybersecurity
Technology Dependency
Business relies on secure transmission/storage of patient-identifiable health and financial information; healthcare companies increasingly targeted; MSO adds incremental cyber risk.
Relevance 85·Dependency 80·Confidence 94
Source evidence
“Our business relies on the secure transmission, storage, and hosting of patient-identifiable health information, financial information, and other sensitive protected information”
Pharmaceutical manufacturers
Customer Exposure
Manufacturer services (distribution, inventory management, data reporting, new product launch support, chargeback administration) and branded distribution services fees tied to WAC are key revenue sources.
Relevance 85·Dependency 75·Confidence 95
Source evidence
“provides services to pharmaceutical manufacturers, including distribution, inventory management, data reporting, new product launch support, and chargeback administration”
Corporate practice of medicine laws
Regulatory Exposure
Adopted Oregon legislation and proposed federal/state laws could restrict Cardinal Health's MSO ownership and management of physician practices, impacting the MSO strategy.
Relevance 85·Dependency 75·Confidence 95
Source evidence
“If these regulations are ultimately adopted in other states in which we operate or plan to operate, our ability to continue to own these businesses in certain jurisdictions would be impacted.”
CVS Health Corporation
Supplier Dependency
Red Oak Sourcing, a 50/50-style sourcing venture with CVS Health through June 2029, negotiates generic pharmaceutical supply contracts for both companies, linking Cardinal Health's generics economics to this partnership.
Relevance 85·Dependency 70·Confidence 95
Source evidence
“Red Oak Sourcing, LLC ("Red Oak Sourcing"), a U.S.-based generic pharmaceutical sourcing venture with CVS Health, negotiates generic pharmaceutical supply contracts on behalf of both companies. The term of Red Oak Sourcing extends through June 2029.”
MSO (management services organization) platforms
Technology Dependency
Pharma segment includes MSO platforms for physician offices; expanded via the ~$1.9B Solaris Health urology MSO acquisition, a strategic growth area.
Relevance 82·Dependency 70·Confidence 90
Source evidence
“we, through The Specialty Alliance, completed the acquisition of Solaris Health, a urology MSO, for a purchase price of approximately $1.9 billion in cash”
Anti-Kickback Statute, Stark Law, False Claims Act
Legal Exposure
MSO businesses face risks under fraud, waste, and abuse laws including the federal Anti-Kickback Statute, Stark Law, and False Claims Act.
Relevance 80·Dependency 70·Confidence 94
Source evidence
“risks arising under or related to fraud, waste, and abuse laws, including the federal Anti-Kickback Statute, the federal self-referral law commonly known as the Stark Law and the federal False Claims Act”
Medicare / Medicaid / 340B
Regulatory Exposure
Some businesses are Medicare-certified suppliers or participate in Medicaid and 340B; noncompliance could cost program participation.
Relevance 80·Dependency 60·Confidence 92
Source evidence
“Some of our businesses are Medicare-certified suppliers or participate in other federal and state healthcare programs, such as state Medicaid programs and the federal 340B drug pricing program.”
Anti-Kickback Statute / False Claims Act
Legal Exposure
DOJ CID under these statutes tied to a 2022 GPO/rheumatology MSO transaction.
Relevance 75·Dependency 50·Confidence 94
Source evidence
“focused on potential violations of the Anti-Kickback Statute and False Claims Act in connection with a 2022 transaction”
Enterprise Resource Planning (ERP) technologies
Technology Dependency
Ongoing ERP implementation, supply chain optimization, and AI/ML initiatives; failures could negatively impact business and internal control over financial reporting.
Relevance 70·Dependency 65·Confidence 90
Source evidence
“if our relationship with critical third-party service providers deteriorates, we could experience negative impacts on our business, financial results, and our internal control over financial reporting.”
Single-source manufacturing facilities
Manufacturing Dependency
Key products or components manufactured at a single facility with limited alternates create manufacturing disruption risk.
Relevance 70·Dependency 65·Confidence 90
Source evidence
“any key products or components that is manufactured at a single manufacturing facility where there are limited alternate facilities.”
IRS NOPAs could add up to roughly $1.8-2.0B including the $400M expense item, affecting effective tax rate and cash flow.
Relevance 70·Dependency 50·Confidence 93
Source evidence
“If the IRS prevails in one or both of these matters, the assessed tax would impact our financial results, effective tax rate, and cash flow.”
EU GDPR and US health information privacy laws
Regulatory Exposure
A cybersecurity incident could result in violations of GDPR and US state/federal patient data laws, leading to fines, litigation, and loss of customers.
Relevance 65·Dependency 60·Confidence 92
Source evidence
“result in a violation of these and other applicable laws and result in a loss of customers and revenues, remediation and other costs, increased insurance premiums, litigation, monetary fines and penalties”
Interest rates / financing cost
Cost Driver
Net interest expense rose from $51M (FY2024) to $348M (FY2026) alongside higher debt and cash payments for interest of $406M.
Relevance 65·Dependency 60·Confidence 90
Source evidence
“Interest expense, net348 215 51”
Euro listed among principal drivers of FX exposure; transactional VAR $15M and translational VAR $2M for the upcoming fiscal year.
Relevance 65·Dependency 55·Confidence 95
Source evidence
“The following foreign currencies represent the principal drivers of our foreign exchange exposure: Canadian dollar, euro, Thai baht, Mexican peso, Chinese renminbi, Australian dollar, British pound, Japanese yen”
oil-based resins
Raw Material Dependency
GMPD's Cardinal Health branded products depend on commodities bought at market or index-linked prices; $457M forecasted exposure with $46M impact from a 10% move.
Relevance 60·Dependency 60·Confidence 90
Source evidence
“We are directly exposed to market price changes for certain commodities, including oil-based resins, nitrile, cotton, diesel fuel, and latex.”
Extreme weather and catastrophic events
Geopolitical Exposure
Extreme weather has damaged properties and disrupted the transportation network causing delivery delays; geopolitical events, trade sanctions, and tariffs also affect operations.
Relevance 60·Dependency 55·Confidence 90
Source evidence
“storms have negatively impacted our transportation network, resulting in delivery delays or disruptions.”
EtO/PFA emission regulations
Cost Driver
Tighter EtO/PFA sterilization emission standards could raise compliance costs and cause supply shortages or reduced surgical procedures.
Relevance 60·Dependency 50·Confidence 90
Source evidence
“If such measures become more widespread, we could experience increased costs to comply with reduced emissions standards and it is possible that we and other industry participants may be unable to effectively sterilize medical products.”
geopolitical_risk
Demand Driver
Commodity price fluctuation during fiscal 2026 attributed in part to the conflict in Iran, affecting Cardinal Health's raw material costs.
Relevance 55·Dependency 50·Confidence 85
Source evidence
“During fiscal 2026, the prices of certain commodities continued to experience fluctuation due in part to the conflict in Iran.”